Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modeling Natural Killer Cell Targeted Immunotherapies.

Silvia Lopez-Lastra1, James P Di Santo2

  • 1Innate Immunity Unit, Institut Pasteur, Paris, France; Inserm U1223, Paris, France; Université Paris-Sud (Paris-Saclay), Paris, France.

Frontiers in Immunology
|April 14, 2017
PubMed
Summary

Human immune system (HIS) mouse models bridge the gap between animal research and human disease complexity. These models advance understanding of natural killer (NK) cell therapies for cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Common γ-chain cytokines induce an epigenomically plastic precursor-like KIT<sup>+</sup> ILC2 state linked to immune disease susceptibility.

The Journal of allergy and clinical immunology·2026
Same author

Tracking HIV-1 DNA fate from cell culture to humanized mice tissues.

Molecular therapy. Advances·2026
Same author

The healthy human global project - Hong Kong: A community-based cross-sectional study of a healthy Asian population.

Cell reports. Medicine·2026
Same author

Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1<sup>+</sup> cDC1 infiltration and activates anti-tumor immunity.

Nature communications·2025
Same author

Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms.

RMD open·2025
Same author

In vivo HIV-1 nuclear condensates safeguard against cGAS and license reverse transcription.

The EMBO journal·2024

Area of Science:

  • Immunology
  • Cancer Biology
  • Translational Medicine

Background:

  • Traditional animal models often fail to replicate the genetic and molecular complexity of human diseases.
  • Human immune system (HIS) mouse models offer a solution by recapitulating human hematopoiesis and tumor immunobiology.
  • Natural killer (NK) cells are crucial innate immune cells with potent anti-tumor activity, making them a focus for cancer therapy.

Purpose of the Study:

  • To review the development and application of HIS mouse models in cancer research.
  • To summarize advancements in adoptive natural killer (NK) cell therapies and novel NK cell sources.
  • To discuss the utility of HIS mice in studying human NK cell-cancer interactions and developing new therapeutic strategies.

Main Methods:

  • Review of literature on immunodeficient mouse strains and their use in cancer research.
Keywords:
cancer immunotherapyhumanized mouse modelsinnate lymphoid cellnatural killer cell immunotherapynatural killer cells

Related Experiment Videos

  • Analysis of recent progress in adoptive NK cell therapies and alternative NK cell generation methods.
  • Evaluation of HIS mouse models for studying human NK cell functions against human cancers.

    • Main Results:

    • HIS mouse models are increasingly valuable for studying human diseases, including cancer.
    • Significant improvements have been made in adoptive NK cell therapies, with ongoing development of new NK cell sources.
    • HIS mice provide a platform to investigate human NK cell-mediated anti-tumor immunity and to refine therapeutic approaches.

    Conclusions:

    • HIS mouse models are essential for overcoming the limitations of traditional animal models in human disease research.
    • Advancements in NK cell therapy hold significant promise for cancer treatment.
    • HIS mice are critical for developing and validating novel NK cell-based cancer immunotherapies.